Late Breaking Abstract - Assessing Inflammatory Response to Air Pollution via VOCs in Exhaled Breath
Air pollution, particularly particulate matter less than 2.5 μg/m³ (PM2.5), is classified as a Group 1 carcinogen and contributes to lung cancer and respiratory diseases. Lung inflammation is a response to pollutants, releasing volatile organic compounds (VOCs) in breath, which could serve as non-invasive markers for assessing inflammation. This randomized double-blind crossover study examined breath VOCs over 24 hours following acute high exposure to PM2.5 in 20 non-smoking, healthy individuals. Participants underwent two separate exposures in the UBC Air Pollution Exposure Lab booth: 300 μg/m³ of PM2.5 from a diesel engine, and to filtered air, spaced a minimum of six weeks apart. Breath collected using Breath Biopsy® before exposure, immediately after, and at 0.5, 1, 3, 6, and 24 hours post-exposure. Samples were analysed by GC-MS, both untargeted and targeted analyses was conducted. iData analysis included univariate analysis and multivariate techniques such as ANOVA simultaneous component analysis (ASCA). ASCA revealed a significant effect of exposure type (300 μg/m³ PM2.5 vs. sham, p < 0.01) and a significant interaction (p < 0.05) between post-exposure time and exposure type. From targeted analysis, inflammation-related compounds significantly increased in individuals exposed to PM2.5 compared to controls. From untargeted analysis, 12 VOCs significantly increased in breath of the 300 μg/m³ PM2.5 group, which diminished in samples collected 24 hours post-exposure. A distinct breath VOC profile is detectable in individuals exposed to inflammation triggers, suggesting that breath VOCs may detect acute airway inflammation and assess respiratory diseases secondary to air pollution.
Authors
- Stephen Lam (ORCID: https://orcid.org/0000-0002-3964-1492)
- Ingrid Elisia (ORCID: https://orcid.org/0000-0001-7182-6609)
- Gerald Krystal (ORCID: https://orcid.org/0000-0002-1961-6281)
- C. Bartolomeu (ORCID: https://orcid.org/0000-0002-6897-363X)
- Agnieszka Smolinska (ORCID: https://orcid.org/0000-0002-1412-4544)
- Max Allsworth
- Michael A. Kerr (ORCID: https://orcid.org/0000-0001-7239-3673)
- Billy Boyle
- Renelle Myers (ORCID: https://orcid.org/0000-0003-4898-2229)
- Lara Pocock
- Elizabeth Crone
Institutions
- BC Cancer Agency (CA)
- Owlstone Medical (United Kingdom) (GB)
Publication Details
- Published
- 2024-09-14
- DOI
- https://doi.org/10.1183/13993003.congress-2024.pa4445
- Primary Topic
- Advanced Chemical Sensor Technologies
- Type
- article
- Field-Weighted Citation Impact
- 0.00